Bicycle Therapeutics Limited Appoints Andy Sandham as Non-Executive Chairman

(BUSINESS WIRE)--Bicycle Therapeutics today announced the appointment of Andy Sandham as non-executive Chairman. Andy brings over 30 years experience in building biotechnology businesses. He will work closely with founders, Sir Gregory Winter, FRS and Christian Heinis, and CEO, Dr John Tite, to drive the discovery and development of a new generation of biotherapeutics using the company’s proprietary bicyclic peptide technology. In addition to Andy’s appointment, Bruce Booth will be joining the Board to replace Regina Hodits as the Atlas Venture representative director.

Back to news